| About the Companion Website |
|
xii | |
| Preface |
|
xiii | |
| Collaborators |
|
xiv | |
|
|
|
1 | (21) |
|
Hashimoto's thyroiditis (chronic autoimmune thyroiditis) |
|
|
1 | (3) |
|
Definition and epidemiology |
|
|
1 | (1) |
|
Etiology and pathogenesis |
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
1 | (1) |
|
|
|
1 | (2) |
|
Illustrations (Figs 1.1--1.4) |
|
|
3 | (1) |
|
Graves' disease (Basedow's disease) |
|
|
4 | (2) |
|
Definition and epidemiology |
|
|
4 | (1) |
|
Etiology and pathogenesis |
|
|
4 | (1) |
|
|
|
4 | (1) |
|
|
|
4 | (1) |
|
|
|
4 | (1) |
|
Illustrations (Figs 1.5 & 1.6) |
|
|
5 | (1) |
|
Subacute thyroiditis (de Quervain's thyroiditis) |
|
|
6 | (2) |
|
Definition and epidemiology |
|
|
6 | (1) |
|
Etiology and pathogenesis |
|
|
6 | (1) |
|
|
|
6 | (1) |
|
|
|
6 | (1) |
|
|
|
6 | (1) |
|
|
|
7 | (1) |
|
|
|
8 | (3) |
|
Definition and epidemiology |
|
|
8 | (1) |
|
Etiology and pathogenesis |
|
|
8 | (1) |
|
|
|
8 | (1) |
|
|
|
8 | (1) |
|
|
|
8 | (2) |
|
Illustrations (Figs 1.8--1.11) |
|
|
10 | (1) |
|
|
|
11 | (11) |
|
Definition and epidemiology |
|
|
11 | (1) |
|
Etiology and pathogenesis |
|
|
11 | (1) |
|
|
|
11 | (1) |
|
|
|
11 | (1) |
|
|
|
12 | (9) |
|
Illustrations (Figs 1.12--1.25) |
|
|
21 | (1) |
|
Chapter 2 Pituitary Gland |
|
|
22 | (25) |
|
|
|
22 | (2) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
|
|
22 | (1) |
|
Illustrations (Figs 2.1--2.3) |
|
|
23 | (1) |
|
Hypothalamic dysgerminoma |
|
|
24 | (1) |
|
|
|
24 | (1) |
|
|
|
24 | (1) |
|
|
|
24 | (1) |
|
|
|
24 | (1) |
|
|
|
24 | (1) |
|
Illustrations (Figs 2.4 & 2.5) |
|
|
24 | (1) |
|
Growth hormone-secreting pituitary tumor |
|
|
25 | (2) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
|
|
25 | (1) |
|
Illustrations (Figs 2.6--2.10) |
|
|
26 | (1) |
|
Prolactin-secreting pituitary tumor |
|
|
27 | (2) |
|
|
|
27 | (1) |
|
|
|
27 | (1) |
|
|
|
27 | (1) |
|
|
|
27 | (1) |
|
|
|
27 | (1) |
|
Illustrations (Figs 2.11--2.13) |
|
|
28 | (1) |
|
Corticotropin-secreting pituitary tumor (Cushing syndrome) |
|
|
29 | (2) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
|
|
29 | (1) |
|
Illustrations (Figs 2.14--2.16) |
|
|
30 | (1) |
|
|
|
31 | (2) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
|
|
31 | (1) |
|
Illustrations (Figs 2.17--2.20) |
|
|
32 | (1) |
|
Clinically nonfunctioning pituitary tumors |
|
|
33 | (2) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
|
|
33 | (1) |
|
Illustrations (Figs 2.21--2.23) |
|
|
34 | (1) |
|
Primary pituitary carcinoma |
|
|
35 | (2) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
|
|
35 | (1) |
|
Illustrations (Figs 2.24--2.27) |
|
|
36 | (1) |
|
|
|
37 | (3) |
|
|
|
37 | (1) |
|
|
|
37 | (1) |
|
|
|
37 | (1) |
|
|
|
37 | (1) |
|
|
|
37 | (2) |
|
Illustrations (Figs 2.28--2.31) |
|
|
39 | (1) |
|
Nontumorous lesions of the pituitary gland and pituitary stalk |
|
|
40 | (3) |
|
|
|
40 | (1) |
|
|
|
40 | (1) |
|
|
|
40 | (1) |
|
|
|
40 | (1) |
|
|
|
40 | (2) |
|
Illustrations (Figs 2.32--2.34) |
|
|
42 | (1) |
|
|
|
43 | (2) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
|
|
43 | (1) |
|
Illustrations (Figs 2.35--2.37) |
|
|
44 | (1) |
|
Tumors metastatic to the pituitary |
|
|
45 | (2) |
|
|
|
45 | (1) |
|
|
|
45 | (1) |
|
|
|
45 | (1) |
|
|
|
45 | (1) |
|
|
|
45 | (1) |
|
Illustrations (Figs 2.38 & 2.39) |
|
|
46 | (1) |
|
|
|
47 | (29) |
|
|
|
47 | (3) |
|
|
|
47 | (1) |
|
|
|
47 | (1) |
|
|
|
47 | (1) |
|
|
|
47 | (1) |
|
|
|
47 | (2) |
|
Illustrations (Figs 3.1--3.4) |
|
|
49 | (1) |
|
|
|
50 | (2) |
|
|
|
50 | (1) |
|
|
|
50 | (1) |
|
|
|
50 | (1) |
|
|
|
50 | (1) |
|
|
|
50 | (1) |
|
Illustrations (Figs 3.5--3.8) |
|
|
51 | (1) |
|
Adrenal-dependent Cushing syndrome |
|
|
52 | (3) |
|
|
|
52 | (1) |
|
|
|
52 | (1) |
|
|
|
52 | (1) |
|
|
|
52 | (1) |
|
|
|
52 | (2) |
|
Illustrations (Figs 3.9--3.14) |
|
|
54 | (1) |
|
Classic congenital adrenal hyperplasia |
|
|
55 | (3) |
|
|
|
55 | (1) |
|
|
|
55 | (1) |
|
|
|
55 | (1) |
|
|
|
55 | (1) |
|
|
|
56 | (1) |
|
Illustrations (Figs 3.15 & 3.16) |
|
|
57 | (1) |
|
|
|
58 | (3) |
|
|
|
58 | (1) |
|
|
|
58 | (1) |
|
|
|
58 | (1) |
|
|
|
58 | (1) |
|
|
|
58 | (2) |
|
Illustrations (Figs 3.17 & 3.18) |
|
|
60 | (1) |
|
|
|
61 | (2) |
|
|
|
61 | (1) |
|
|
|
61 | (1) |
|
Procedure and keys to successful AVS |
|
|
61 | (1) |
|
|
|
61 | (1) |
|
Illustrations (Figs 3.19 & 3.20) |
|
|
62 | (1) |
|
Primary adrenal failure (Addison's disease) |
|
|
63 | (2) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
|
|
63 | (1) |
|
Illustrations (Figs 3.21--3.23) |
|
|
64 | (1) |
|
|
|
65 | (3) |
|
|
|
65 | (1) |
|
|
|
65 | (1) |
|
|
|
65 | (1) |
|
|
|
65 | (1) |
|
|
|
65 | (2) |
|
Illustrations (Figs 3.24--3.30) |
|
|
67 | (1) |
|
|
|
68 | (4) |
|
|
|
68 | (1) |
|
|
|
68 | (1) |
|
|
|
68 | (1) |
|
|
|
68 | (1) |
|
|
|
68 | (3) |
|
Illustrations (Figs 3.31--3.35) |
|
|
71 | (1) |
|
|
|
72 | (2) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
|
|
72 | (1) |
|
Illustrations (Figs 3.36 & 3.37) |
|
|
73 | (1) |
|
Tumors metastatic to the adrenal glands |
|
|
74 | (2) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
|
|
74 | (1) |
|
Illustrations (Figs 3.38 & 3.39) |
|
|
75 | (1) |
|
|
|
76 | (24) |
|
|
|
76 | (4) |
|
Diabetes and cardiovascular disease |
|
|
76 | (1) |
|
Definition and pathogenesis |
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
76 | (1) |
|
|
|
77 | (1) |
|
|
|
77 | (2) |
|
Illustrations (Figs 4.1--4.5) |
|
|
79 | (1) |
|
Skin diseases associated with diabetes |
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
|
|
80 | (1) |
|
Illustrations (Figs 4.6 & 4.7) |
|
|
81 | (1) |
|
|
|
81 | (6) |
|
|
|
81 | (1) |
|
Pathophysiology and etiology |
|
|
81 | (1) |
|
|
|
81 | (1) |
|
|
|
82 | (1) |
|
|
|
82 | (4) |
|
Illustrations (Figs 4.8--4.22) |
|
|
86 | (1) |
|
|
|
87 | (2) |
|
|
|
87 | (1) |
|
|
|
87 | (1) |
|
|
|
87 | (1) |
|
|
|
87 | (1) |
|
Illustrations (Figs 4.23 & 4.24) |
|
|
88 | (1) |
|
|
|
89 | (3) |
|
|
|
89 | (1) |
|
|
|
89 | (1) |
|
|
|
89 | (1) |
|
|
|
89 | (1) |
|
|
|
90 | (1) |
|
Illustrations (Figs 4.25--4.28) |
|
|
91 | (1) |
|
|
|
92 | (3) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (1) |
|
|
|
92 | (2) |
|
Illustrations (Figs 4.29--4.38) |
|
|
94 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (1) |
|
|
|
95 | (1) |
|
Illustrations (Figs 4.39--4.42) |
|
|
96 | (1) |
|
|
|
96 | (2) |
|
|
|
96 | (1) |
|
|
|
96 | (1) |
|
|
|
96 | (1) |
|
|
|
96 | (1) |
|
|
|
97 | (1) |
|
Illustrations (Figs 4.43--4.45) |
|
|
97 | (1) |
|
|
|
98 | (2) |
|
|
|
98 | (1) |
|
|
|
98 | (1) |
|
|
|
98 | (1) |
|
|
|
98 | (1) |
|
|
|
98 | (1) |
|
Illustrations (Figs 4.46--4.48) |
|
|
99 | (1) |
|
Chapter 5 Bone and Mineral Metabolism |
|
|
100 | (55) |
|
|
|
100 | (3) |
|
|
|
100 | (1) |
|
|
|
100 | (1) |
|
|
|
101 | (1) |
|
|
|
101 | (1) |
|
|
|
101 | (1) |
|
Illustrations (Figs 5.1--5.5) |
|
|
102 | (1) |
|
Primary hyperparathyroidism |
|
|
103 | (5) |
|
|
|
103 | (1) |
|
|
|
103 | (1) |
|
|
|
103 | (1) |
|
|
|
103 | (1) |
|
|
|
104 | (4) |
|
Illustrations (Figs 5.6--5.16) |
|
|
108 | (1) |
|
|
|
108 | (3) |
|
|
|
108 | (1) |
|
|
|
108 | (1) |
|
|
|
109 | (1) |
|
|
|
109 | (1) |
|
|
|
110 | (1) |
|
Illustrations (Figs 5.17--5.19) |
|
|
110 | (1) |
|
|
|
111 | (2) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
111 | (1) |
|
|
|
112 | (1) |
|
Illustrations (Figs 5.20 & 5.21) |
|
|
112 | (1) |
|
|
|
113 | (3) |
|
|
|
113 | (1) |
|
|
|
113 | (1) |
|
|
|
113 | (1) |
|
|
|
114 | (1) |
|
|
|
114 | (2) |
|
Illustrations (Figs 5.22--5.28) |
|
|
116 | (1) |
|
|
|
116 | (5) |
|
|
|
116 | (1) |
|
|
|
116 | (1) |
|
|
|
117 | (1) |
|
|
|
118 | (1) |
|
|
|
118 | (2) |
|
Illustrations (Figs 5.29--5.35) |
|
|
120 | (1) |
|
|
|
121 | (4) |
|
|
|
121 | (1) |
|
|
|
121 | (1) |
|
|
|
121 | (1) |
|
|
|
121 | (1) |
|
|
|
122 | (2) |
|
Illustrations (Figs 5.36--5.40) |
|
|
124 | (1) |
|
|
|
125 | (4) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
125 | (1) |
|
|
|
126 | (1) |
|
|
|
126 | (2) |
|
Illustrations (Figs 5.41--5.47) |
|
|
128 | (1) |
|
Selected sclerosing bone disorders |
|
|
129 | (3) |
|
|
|
129 | (1) |
|
|
|
129 | (1) |
|
|
|
129 | (1) |
|
|
|
129 | (1) |
|
|
|
130 | (1) |
|
|
|
130 | (1) |
|
Illustrations (Figs 5.48--5.51) |
|
|
131 | (1) |
|
|
|
132 | (2) |
|
|
|
132 | (1) |
|
|
|
132 | (1) |
|
|
|
132 | (1) |
|
|
|
132 | (1) |
|
Illustrations (Figs 5.52--5.54) |
|
|
133 | (1) |
|
|
|
134 | (1) |
|
|
|
134 | (1) |
|
|
|
134 | (1) |
|
|
|
134 | (1) |
|
|
|
134 | (1) |
|
Illustrations (Figs 5.55 & 5.56) |
|
|
134 | (1) |
|
Progressive diaphyseal dysplasia (Camurati--Engelmanri disease) |
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
135 | (1) |
|
|
|
136 | (1) |
|
Hepatitis C-associated osteosclerosis |
|
|
136 | (2) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
|
|
136 | (1) |
|
Illustrations (Figs 5.58--5.60) |
|
|
137 | (1) |
|
Familial high bone mass phenotype due to Lrp5 mutation |
|
|
138 | (1) |
|
|
|
138 | (1) |
|
|
|
138 | (1) |
|
|
|
138 | (1) |
|
|
|
138 | (1) |
|
Illustrations (Figs 5.61 & 5.62) |
|
|
138 | (1) |
|
|
|
139 | (2) |
|
|
|
139 | (1) |
|
|
|
139 | (1) |
|
|
|
139 | (1) |
|
|
|
139 | (1) |
|
Illustrations (Figs 5.63--5.65) |
|
|
140 | (1) |
|
|
|
141 | (2) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
|
|
141 | (1) |
|
Illustrations (Figs 5.66 & 5.67) |
|
|
142 | (1) |
|
|
|
143 | (2) |
|
|
|
143 | (1) |
|
|
|
143 | (1) |
|
|
|
143 | (1) |
|
|
|
144 | (1) |
|
|
|
144 | (1) |
|
Illustrations (Figs 5.68 & 5.69) |
|
|
145 | (1) |
|
|
|
145 | (5) |
|
|
|
145 | (1) |
|
|
|
145 | (1) |
|
|
|
145 | (2) |
|
|
|
147 | (1) |
|
|
|
147 | (2) |
|
Illustrations (Figs 5.70--5.77) |
|
|
149 | (1) |
|
|
|
150 | (2) |
|
Osteoporosis--pseudoglioma (OPPG) syndrome |
|
|
150 | (1) |
|
|
|
150 | (1) |
|
|
|
150 | (1) |
|
|
|
150 | (1) |
|
|
|
150 | (1) |
|
|
|
150 | (1) |
|
Illustrations (Figs 5.78--5.81) |
|
|
151 | (1) |
|
Hajdu--Cheney syndrome (hereditary osteodysplasia with acro-osteolysis) |
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
152 | (1) |
|
|
|
153 | (2) |
|
|
|
153 | (1) |
|
|
|
153 | (1) |
|
|
|
153 | (1) |
|
|
|
153 | (1) |
|
|
|
154 | (1) |
|
Illustrations (Figs 5.83 & 5.84) |
|
|
154 | (1) |
|
|
|
155 | (51) |
|
|
|
155 | (3) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
155 | (1) |
|
|
|
156 | (1) |
|
Illustrations (Figs 6.1--6.4) |
|
|
157 | (1) |
|
|
|
158 | (5) |
|
Definition and epidemiology |
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
158 | (1) |
|
|
|
159 | (3) |
|
Illustrations (Figs 6.5--6.8) |
|
|
162 | (1) |
|
|
|
163 | (3) |
|
|
|
163 | (1) |
|
|
|
163 | (1) |
|
|
|
163 | (1) |
|
|
|
163 | (1) |
|
|
|
163 | (2) |
|
Illustrations (Figs 6.9 & 6.10) |
|
|
165 | (1) |
|
|
|
166 | (2) |
|
|
|
166 | (1) |
|
|
|
166 | (1) |
|
|
|
166 | (1) |
|
|
|
167 | (1) |
|
Illustrations (Figs 6.11--6.13) |
|
|
168 | (5) |
|
|
|
169 | (1) |
|
|
|
169 | (1) |
|
|
|
169 | (1) |
|
|
|
169 | (1) |
|
|
|
169 | (1) |
|
|
|
169 | (3) |
|
Illustrations (Figs 6.14--6.16) |
|
|
172 | (1) |
|
|
|
173 | (2) |
|
|
|
173 | (1) |
|
|
|
173 | (1) |
|
|
|
173 | (1) |
|
|
|
174 | (1) |
|
Illustrations (Figs 6.17--6.19) |
|
|
174 | (1) |
|
|
|
175 | (3) |
|
|
|
175 | (1) |
|
|
|
175 | (1) |
|
|
|
175 | (1) |
|
|
|
175 | (1) |
|
|
|
175 | (2) |
|
Illustrations (Figs 6.20--6.23) |
|
|
177 | (1) |
|
|
|
178 | (3) |
|
|
|
178 | (1) |
|
|
|
178 | (1) |
|
|
|
178 | (1) |
|
|
|
179 | (1) |
|
Illustrations (Figs 6.24 & 6.25) |
|
|
180 | (1) |
|
|
|
181 | (7) |
|
Definition and epidemiology |
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
181 | (1) |
|
|
|
182 | (5) |
|
Illustrations (Figs 6.26--6.30) |
|
|
187 | (1) |
|
|
|
188 | (6) |
|
|
|
188 | (1) |
|
|
|
188 | (1) |
|
|
|
188 | (1) |
|
|
|
188 | (1) |
|
|
|
189 | (4) |
|
Illustrations (Figs 6.31--6.35) |
|
|
193 | (1) |
|
|
|
194 | (4) |
|
|
|
194 | (1) |
|
|
|
194 | (1) |
|
|
|
194 | (1) |
|
|
|
194 | (1) |
|
|
|
195 | (2) |
|
Illustrations (Figs 6.36--6.39) |
|
|
197 | (1) |
|
Hyperandrogenism in women |
|
|
198 | (3) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (1) |
|
|
|
198 | (2) |
|
Illustrations (Figs 6.40--6.42) |
|
|
200 | (1) |
|
Polycystic ovary syndrome |
|
|
201 | (3) |
|
|
|
201 | (1) |
|
|
|
201 | (1) |
|
|
|
201 | (1) |
|
|
|
201 | (1) |
|
|
|
201 | (2) |
|
Illustrations (Figs 6.43--6.45) |
|
|
203 | (1) |
|
|
|
204 | (2) |
|
|
|
204 | (1) |
|
|
|
204 | (1) |
|
|
|
204 | (1) |
|
|
|
204 | (1) |
|
|
|
204 | (1) |
|
Illustrations (Fig. 6.46) |
|
|
205 | (1) |
|
Chapter 7 Mucocutaneous Manifestations of Endocrine Disorders |
|
|
206 | (21) |
|
|
|
206 | (3) |
|
|
|
206 | (1) |
|
|
|
206 | (1) |
|
|
|
206 | (1) |
|
|
|
207 | (1) |
|
|
|
207 | (1) |
|
Illustrations (Figs 7.1 & 7.2) |
|
|
208 | (1) |
|
|
|
209 | (2) |
|
|
|
209 | (1) |
|
|
|
209 | (1) |
|
|
|
209 | (1) |
|
|
|
209 | (1) |
|
|
|
209 | (1) |
|
Illustrations (Figs 7.3 & 7.4) |
|
|
210 | (1) |
|
|
|
211 | (4) |
|
|
|
211 | (1) |
|
|
|
211 | (1) |
|
|
|
211 | (1) |
|
|
|
211 | (1) |
|
|
|
212 | (2) |
|
Illustrations (Figs 7.5 & 7.6) |
|
|
214 | (1) |
|
|
|
215 | (2) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
|
|
215 | (1) |
|
|
|
216 | (1) |
|
|
|
216 | (1) |
|
|
|
217 | (2) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
|
|
217 | (1) |
|
Illustrations (Figs 7.8 & 7.9) |
|
|
218 | (1) |
|
Necrolytic migratory erythema |
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
219 | (1) |
|
|
|
220 | (3) |
|
|
|
220 | (1) |
|
|
|
220 | (1) |
|
|
|
220 | (1) |
|
|
|
220 | (1) |
|
|
|
220 | (2) |
|
Illustrations (Figs 7.11--7.13) |
|
|
222 | (1) |
|
|
|
223 | (4) |
|
|
|
223 | (1) |
|
|
|
223 | (1) |
|
|
|
223 | (1) |
|
|
|
223 | (1) |
|
|
|
223 | (2) |
|
Illustrations (Figs 7.14--7.16) |
|
|
225 | (2) |
| Index |
|
227 | |